Summary

Mol Med Rep. 2017 Sep;16(3):3034-3040. doi: 10.3892/mmr.2017.7015. Epub 2017 Jul 15.

PTPRQ as a potential biomarker for idiopathic normal pressure hydrocephalus.

Abstract:

Idiopathic normal pressure hydrocephalus (iNPH) is caused by the accumulation of cerebrospinal fluid (CSF) and is characterized by gait disturbance, urinary incontinence, and dementia. iNPH dementia is treatable by shunt operation; however, since the cognitive symptoms of iNPH are often similar to those of other dementias, including Alzheimer's disease (AD), accurate diagnosis of iNPH is difficult. To overcome this problem, the identification of novel diagnostic markers to distinguish iNPH and AD is warranted. Using comparative proteomic analysis of CSF from patients with iNPH and AD, protein tyrosine phosphatase receptor type Q (PTPRQ) was identified as a candidate biomarker protein for discriminating iNPH from AD. ELISA analysis indicated that the PTPRQ concentration in the CSF was significantly higher in patients with iNPH compared with those with AD. In addition, the PTPRQ concentration in the CSF of non‑responders to shunt operation (SNRs) tended to be relatively lower compared with that in the responders. PTPRQ may be a useful biomarker for discriminating between patients with iNPH and AD, and may be a potential companion biomarker to identify SNRs among patients with iNPH. Additional large‑scale analysis may aid in understanding the novel aspects of iNPH.

日本語要旨:

正常圧水頭症患者由来の髄液プロテオミクス解析結果から、シャント術が奏効しや すい患者群を、アルツハイマー病およびシャント術が奏効しにくい正常圧水頭症患者群から識別できる可能性を持つタンパク因子を明らかにした。

PMID:  28714010

前ページへ戻る

PAGE TOP